FindTrial
Sign In

Comparison of Efficacy of TCNS and Biothesiometry in Detecting Diabetic Peripheral Neuropathy

Assessment of Accuracy of the Toronto Clinical Neuropathy Scoring System and Vibration Perception Threshold in Diagnosing Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus Patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094074
Enrollment
86
Registered
2025-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: NIL: NIL

Sponsors

All India Institute of Medical Sciences Bhopal
Lead Sponsor
Dr Rajnish Joshi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of diabetes mellitus

Exclusion criteria

Exclusion criteria: Individuals with active foot ulcers or amputations Patients with other causes of peripheral neuropathy like Hansens disease, deficiencies etc.

Design outcomes

Primary

MeasureTime frame
To compare the diagnostic accuracy of the Toronto Clinical Neuropathy Scoring System and Vibration Perception Threshold with nerve conduction studies in detecting diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.Timepoint: At 18 months—

Secondary

MeasureTime frame
To assess the correlation between the duration of diabetes & NCS parameters. Timepoint: At 18 months;To assess the correlation between glycaemic control, lipid profile & NCS parameters.Timepoint: At 18 months—

Countries

India

Contacts

Public ContactHelana Jabeen

All India Institute of Medical Sciences, Bhopal

puri.pmr@aiimsbhopal.edu.in9645332656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026